| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 751 | 474 |
| Net decrease in cash, cash equivalents, and restricted cash | -5,149 | 8,908 |
| Cash and cash equivalents at beginning of period | 16,339 | - |
| Cash and cash equivalents at end of period | 11,190 | - |
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU)